Search

Your search keyword '"VANDENDRIESSCHE, T"' showing total 296 results

Search Constraints

Start Over You searched for: Author "VANDENDRIESSCHE, T" Remove constraint Author: "VANDENDRIESSCHE, T"
296 results on '"VANDENDRIESSCHE, T"'

Search Results

10. Genetic aspects and research development in haemostasis

11. Dual antiplatelet therapy duration after coronary stenting in clinical practice: results of an EAPCI survey

17. Next-generation muscle-directed gene therapy by in silico vector design

18. CRISPR/Cas9-mediated editing for dominant genetic disorders: efficient excision of trinucleotide repeat expansion in myotonic dystrophy

20. Next-generation muscle-directed gene therapy using skeletal-muscle specific transcriptional modules identified by genome-wide computational analysis

21. Intravenous administration of lentiviral vectors expressing hyperfunctional factor IX converts severe into mild hemophilia B in a canine model

22. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPSCs

23. Dual antiplatelet therapy duration after coronary stenting in clinical practice: Results of an EAPCI survey

25. Intrinsic cell memory reinforces myogenic commitment of pericyte-derived iPS

27. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism

28. Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases

29. Translating the genomics revolution: The need for an international gene therapy consortium for monogenic diseases

30. Long-term expression of human coagulation factor VIII and correction of hemophilia A after in vivo retroviral gene transfer in factor VIII-deficient mice

35. Efficient lentiviral transduction and improved engraftment of human bone marrow mesenchymal celles.

36. Alteration of Cardiac Progenitor Cell Potency in GRMD Dogs

40. Thrombospondin-2 prevents cardiac injury and dysfunction in viral myocarditis through the activation of regulatory T-cells

43. DEVELOPMENT AND ANALYSIS OF RETROVIRAL VECTORS EXPRESSING HUMAN FACTOR-VIII AS A POTENTIAL GENE-THERAPY FOR HEMOPHILIA-A

44. Inhibition of clinical human immunodeficiency virus (HIV) type 1 isolates in primary CD4+ T lymphocytes by retroviral vectors expressing anti-HIV genes

45. Relevance of an Academic GMP Pan-European Vector Infra-Structure (PEVI)

46. POSTHARVEST METABOLOMICS

47. Therapeutic levels of human factor VIII in mice implanted with encapsulated cells : potential for gene therapy of hemophilia A

Catalog

Books, media, physical & digital resources